Mechanisms of extrahepatic vasodilation in portal hypertension
暂无分享,去创建一个
[1] F. Lammert,et al. Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats , 2007, Hepatology.
[2] Vicente Arroyo,et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis , 2007, Postgraduate Medical Journal.
[3] M. Tsai. Splanchnic and systemic vasodilatation: the patient. , 2007, Journal of clinical gastroenterology.
[4] Y. Iwakiri. The Molecules: Mechanisms of Arterial Vasodilatation Observed in the Splanchnic and Systemic Circulation in Portal Hypertension , 2007, Journal of clinical gastroenterology.
[5] J. Henriksen,et al. The Systemic Circulation in Cirrhosis , 2007 .
[6] T. Sauerbruch,et al. Vascular dysfunction in human and rat cirrhosis: Role of receptor‐desensitizing and calcium‐sensitizing proteins , 2007, Hepatology.
[7] J. Schölmerich,et al. Role of NPY for vasoregulation in the splanchnic circulation during portal hypertension , 2007, Peptides.
[8] J. Bełtowski,et al. Hydrogen sulfide (H2S) - the third gas of interest for pharmacologists. , 2007, Pharmacological reports : PR.
[9] L. Moezi,et al. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB1 and VR1 receptors , 2006, British journal of pharmacology.
[10] T. Sauerbruch,et al. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis , 2006, Gut.
[11] A. Geerts,et al. Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study , 2006, Liver international : official journal of the International Association for the Study of the Liver.
[12] R. Moreau,et al. Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M. , 2006, Journal of hepatology.
[13] R. Schwabe,et al. Toll-like receptor signaling in the liver. , 2006, Gastroenterology.
[14] R. Groszmann,et al. Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[15] H. Fukui,et al. Local regulator adrenomedullin contributes to the circulatory disturbance in cirrhotic rats. , 2006, World journal of gastroenterology.
[16] J. Schölmerich,et al. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension. , 2006, Journal of hepatology.
[17] K. Jakobs,et al. Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats. , 2006, Gastroenterology.
[18] M. Robbin,et al. Gastric pneumatosis following nasogastric tube placement: a case report with literature review , 2006, Emergency Radiology.
[19] T. Roskams,et al. A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis , 2005, Hepatology.
[20] M. Ebrahimkhani,et al. Hydrogen sulphide and the hyperdynamic circulation in cirrhosis: a hypothesis , 2005, Gut.
[21] P. Pontisso,et al. Haeme oxygenase mediates hyporeactivity to phenylephrine in the mesenteric vessels of cirrhotic rats with ascites , 2005, Gut.
[22] Y. Chung,et al. Gastric pneumatosis after endoscopic argon plasma coagulation. , 2005, Annals of the Academy of Medicine, Singapore.
[23] A. de Gottardi,et al. Basic Studies , 2005 .
[24] J. Schölmerich,et al. Up-regulation of nNOS and associated increase in nitrergic vasodilation in superior mesenteric arteries in pre-hepatic portal hypertension. , 2005, Journal of hepatology.
[25] Carmina Montoliu,et al. Correlation of nitric oxide and atrial natriuretic peptide changes with altered cGMP homeostasis in liver cirrhosis , 2005, Liver international : official journal of the International Association for the Study of the Liver.
[26] R. Schrier,et al. Ascites and Renal Dysfunction in Liver Disease , 2005 .
[27] R. Moreau,et al. Norfloxacin reduces aortic NO synthases and proinflammatory cytokine up-regulation in cirrhotic rats: role of Akt signaling. , 2005, Gastroenterology.
[28] M. Aller,et al. Proinflammatory Liver and Antiinflammatory Intestinal Mediators Involved in Portal Hypertensive Rats , 2005, Mediators of inflammation.
[29] G. Mauco,et al. Gender differences in vascular reactivity of aortas from rats with and without portal hypertension , 2005, Journal of gastroenterology and hepatology.
[30] T. Sauerbruch,et al. Vascular, hemodynamic and renal effects of low‐dose losartan in rats with secondary biliary cirrhosis , 2005, Liver international : official journal of the International Association for the Study of the Liver.
[31] Robert J. Lefkowitz,et al. Transduction of Receptor Signals by ß-Arrestins , 2005, Science.
[32] Shou-Dong Lee,et al. Vascular contractile response and signal transduction in endothelium-denuded aorta from cirrhotic rats. , 2005, World journal of gastroenterology.
[33] W. Jiménez,et al. The role of nitric oxide in the pathogenesis of systemic and splanchnic vasodilation in cirrhotic rats before and after the onset of ascites , 2005, Liver international : official journal of the International Association for the Study of the Liver.
[34] Xuesong Chen,et al. Impaired agonist-dependent myosin phosphorylation and decreased RhoA in rat portal hypertensive mesenteric vasculature. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[35] W. Jiménez,et al. Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors , 2005, Gut.
[36] A. Lemberg,et al. Role of heme oxygenase/carbon monoxide pathway on the vascular response to noradrenaline in portal hypertensive rats , 2005, Clinical and experimental pharmacology & physiology.
[37] A. Stefanov,et al. Ca2+-sensitivity and cGMP-independent effects of NO in vascular smooth muscle. , 2005, Nitric oxide : biology and chemistry.
[38] S. Doggrell,et al. Evidence for, and importance of, cGMP-independent mechanisms with NO and NO donors on blood vessels and platelets. , 2005, Current vascular pharmacology.
[39] C. Fernández-Rodríguez,et al. Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis , 2004, Liver international : official journal of the International Association for the Study of the Liver.
[40] P. Hellstrand,et al. Nitric oxide relaxes rat tail artery smooth muscle by cyclic GMP-independent decrease in calcium sensitivity of myofilaments. , 2004, Cell calcium.
[41] M. Serra,et al. Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis. , 2004, Journal of hepatology.
[42] S. Brain,et al. Vascular actions of calcitonin gene-related peptide and adrenomedullin. , 2004, Physiological reviews.
[43] W. Sessa. eNOS at a glance , 2004, Journal of Cell Science.
[44] D. Kendall,et al. The complexities of the cardiovascular actions of cannabinoids , 2004, British journal of pharmacology.
[45] R. Schrier,et al. Increased vascular heme oxygenase‐1 expression contributes to arterial vasodilation in experimental cirrhosis in rats , 2004, Hepatology.
[46] I. Colle,et al. Vascular hyporesponsiveness in the mesenteric artery of anaesthetized rats with cirrhosis and portal hypertension: an in-vivo study , 2004, European journal of gastroenterology & hepatology.
[47] N. Abraham,et al. Role of the Heme Oxygenases in Abnormalities of the Mesenteric Circulation in Cirrhotic Rats , 2004, Journal of Pharmacology and Experimental Therapeutics.
[48] N. Minamino,et al. Adrenomedullin contributes to vascular hyporeactivity in cirrhotic rats with ascites via a release of nitric oxide , 2004, Scandinavian journal of gastroenterology.
[49] Miguel Ángel Martínez,et al. Adrenomedullin, a Vasodilator Peptide Implicated in Hemodynamic Alterations of Liver Cirrhosis Relationship to Nitric Oxide , 1999, Digestive Diseases and Sciences.
[50] R. Groszmann,et al. Bacterial translocation up‐regulates GTP‐cyclohydrolase I in mesenteric vasculature of cirrhotic rats , 2003, Hepatology.
[51] R. Challiss,et al. Non-visual GRKs: are we seeing the whole picture? , 2003, Trends in pharmacological sciences.
[52] Jian-hua Ai,et al. Heat shock protein 90 is responsible for hyperdynamic circulation in portal hypertensive rats. , 2003, World journal of gastroenterology.
[53] F. Hofmann,et al. Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice. , 2003, Circulation research.
[54] F. Hofmann,et al. Physiology and Pathophysiology of Vascular Signaling Controlled by Cyclic Guanosine 3′,5′-Cyclic Monophosphate–Dependent Protein Kinase , 2003 .
[55] R. Groszmann,et al. Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats. , 2003, Gastroenterology.
[56] R. Lefkowitz,et al. Multifaceted roles of β-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling , 2003 .
[57] Ç. Karaca,et al. Adrenomedullin in cirrhotic and non-cirrhotic portal hypertension. , 2003, World journal of gastroenterology.
[58] A. Somlyo,et al. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. , 2003, Physiological reviews.
[59] G. Jennings,et al. The Effect of Selective Intestinal Decontamination on the Hyperdynamic Circulatory State in Cirrhosis , 2003, Annals of Internal Medicine.
[60] P. Cahill,et al. The role of nitric oxide synthase isoforms in extrahepatic portal hypertension: studies in gene-knockout mice. , 2003, Gastroenterology.
[61] H. Qian,et al. Arresting angiotensin type 1 receptors , 2003, Trends in Endocrinology & Metabolism.
[62] H. Nischalke,et al. Portal hypertension is associated with increased mRNA levels of vasopressor G‐protein‐coupled receptors in human hepatic arteries , 2003, European journal of clinical investigation.
[63] D. Webb,et al. Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide , 2003, Gut.
[64] R. Busse,et al. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.
[65] J. Reichen,et al. Endothelial, but not the inducible, nitric oxide synthase is detectable in normal and portal hypertensive rats. , 2002, Liver.
[66] R. Groszmann,et al. Mice with targeted deletion of eNOS develop hyperdynamic circulation associated with portal hypertension. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[67] R. Andriantsitohaina,et al. Endothelial COX-1 and -2 differentially affect reactivity of MVB in portal hypertensive rats. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[68] M. Koglin,et al. Biliverdin IX is an endogenous inhibitor of soluble guanylyl cyclase. , 2002, Biochemical pharmacology.
[69] R. Moreau,et al. Role of shear stress in aortic eNOS up-regulation in rats with biliary cirrhosis. , 2002, Gastroenterology.
[70] R. Groszmann,et al. Phosphorylation of eNOS initiates excessive NO production in early phases of portal hypertension. , 2002, American journal of physiology. Heart and circulatory physiology.
[71] W. Chu,et al. Emphysematous gastritis associated with gastric infarction in a patient with adult polycystic renal disease: CT diagnosis. , 2002, AJR. American journal of roentgenology.
[72] R. Cunha,et al. Adenosine A2A receptors in portal hypertension: their role in the abnormal response to adenosine of the cranial mesenteric artery in rabbits , 2002, British journal of pharmacology.
[73] R. Bataller,et al. Increased plasma levels of neuropeptide Y in hepatorenal syndrome. , 2002, Journal of hepatology.
[74] R. Lefkowitz,et al. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. , 2002, Journal of cell science.
[75] R. Martı́n-Ruiz,et al. Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. , 2002, Gastroenterology.
[76] D. Helfman,et al. Post-transcriptional down-regulation of ROCKI/Rho-kinase through an MEK-dependent pathway leads to cytoskeleton disruption in Ras-transformed fibroblasts. , 2002, Molecular biology of the cell.
[77] W. Sessa,et al. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? , 2001, The Journal of pharmacology and experimental therapeutics.
[78] T. Sauerbruch,et al. Contractile hyporesponsiveness of hepatic arteries in humans with cirrhosis: Evidence for a receptor‐specific mechanism , 2001, Hepatology.
[79] R. Lefkowitz,et al. Beta-Arrestins: new roles in regulating heptahelical receptors' functions. , 2001, Cellular signalling.
[80] M. Gimeno,et al. Nitric oxide synthase activity in the splanchnic vasculature of patients with cirrhosis: relationship with hemodynamic disturbances. , 2001, Journal of hepatology.
[81] R. Moreau,et al. Role of small-conductance Ca2+-dependent K+ channels in in vitro nitric oxide-mediated aortic hyporeactivity to alpha-adrenergic vasoconstriction in rats with cirrhosis. , 2001, Journal of hepatology.
[82] A. Sanyal,et al. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis , 2001, Nature Medicine.
[83] G. Pfitzer. highlighted topics Signal Transduction in Smooth Muscle Invited Review: Regulation of myosin phosphorylation in smooth muscle , 2022 .
[84] R. Lefkowitz,et al. Expanding roles for beta-arrestins as scaffolds and adapters in GPCR signaling and trafficking. , 2001, Current opinion in cell biology.
[85] T. Hunter,et al. Guanylyl Cyclase-linked Natriuretic Peptide Receptors: Structure and Regulation* , 2001, The Journal of Biological Chemistry.
[86] S. Ferguson,et al. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. , 2001, Pharmacological reviews.
[87] J. García-Estañ,et al. Mesenteric hyporesponsiveness in cirrhotic rats with ascites : role of cGMP and K+ channels , 2000 .
[88] R. Schrier,et al. Update on peripheral arterial vasodilation, ascites and hepatorenal syndrome in cirrhosis. , 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[89] R. Moreau,et al. Evidence for an endothelium‐derived hyperpolarizing factor in the superior mesenteric artery from rats with cirrhosis , 2000, Hepatology.
[90] F. Hofmann,et al. Mechanisms of NO/cGMP-dependent vasorelaxation. , 2000, Circulation research.
[91] H. Schild,et al. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study , 2000, Gut.
[92] R. Moreau,et al. Changes in protein kinase C isoforms in association with vascular hyporeactivity in cirrhotic rat aortas. , 2000, Gastroenterology.
[93] F. Hofmann,et al. Rising behind NO: cGMP-dependent protein kinases. , 2000, Journal of cell science.
[94] P. Hayes,et al. Selective alteration of agonist-mediated contraction in hepatic arteries isolated from patients with cirrhosis. , 2000, Gastroenterology.
[95] A. Somlyo,et al. Signal transduction by G‐proteins, Rho‐kinase and protein phosphatase to smooth muscle and non‐muscle myosin II , 2000, The Journal of physiology.
[96] J. García-Estañ,et al. Mesenteric hyporesponsiveness in cirrhotic rats with ascites: role of cGMP and K+ channels. , 2000, Clinical science.
[97] R. Groszmann,et al. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. , 1999, The Journal of clinical investigation.
[98] R. Moreau,et al. Relationship between vascular reactivity in vitro and blood flows in rats with cirrhosis. , 1999, Clinical science.
[99] C. Chagneau,et al. Abnormal regulation of aortic NOS2 and NOS3 activity and expression from portal vein‐stenosed rats after lipopolysaccharide administration , 1999, Hepatology.
[100] R. Groszmann,et al. Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[101] R. Busse,et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.
[102] M. Bünemann,et al. G‐protein coupled receptor kinases as modulators of G‐protein signalling , 1999, The Journal of physiology.
[103] R. Moreau,et al. Vascular nitric oxide production during the development of two experimental models of portal hypertension. , 1999, Journal of hepatology.
[104] R. Groszmann,et al. NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[105] T. Sauerbruch,et al. Altered adrenergic responsiveness of endothelium-denuded hepatic arteries and portal veins in patients with cirrhosis. , 1999, Gastroenterology.
[106] C. Chagneau,et al. Endothelium-dependent blunted membrane potential responses to ATP-sensitive K+ channel modulators in aortae from rats with cirrhosis. , 1999, Journal of hepatology.
[107] X. Wu,et al. Pharmacomechanical coupling: the role of calcium, G-proteins, kinases and phosphatases. , 1999, Reviews of physiology, biochemistry and pharmacology.
[108] T. Sauerbruch,et al. Nitrite and nitrate levels in patients with cirrhosis of the liver: influence of kidney function and fasting state. , 1999, Scandinavian journal of gastroenterology.
[109] R. Groszmann,et al. Enhanced release of nitric oxide in response to changes in flow and shear stress in the superior mesenteric arteries of portal hypertensive rats , 1998, Hepatology.
[110] J. Prieto,et al. Circulating adrenomedullin in cirrhosis: relationship to hyperdynamic circulation. , 1998, Journal of hepatology.
[111] J. García-Estañ,et al. Role of cyclic guanosine monophosphate and K+ channels as mediators of the mesenteric vascular hyporesponsiveness in portal hypertensive rats , 1998, Hepatology.
[112] R. Moreau,et al. Protein kinase C alterations in aortic vascular smooth muscle cells from rats with cirrhosis. , 1998, Journal of hepatology.
[113] R. Bataller,et al. Increased adrenomedullin levels in cirrhosis: relationship with hemodynamic abnormalities and vasoconstrictor systems. , 1998, Gastroenterology.
[114] P. Cahill,et al. Enhanced cyclooxygenase‐1 expression within the superior mesenteric artery of portal hypertensive rats: Role in the hyperdynamic circulation , 1998, Hepatology.
[115] E. Hanisch,et al. Time course-dependent evolution of nitric oxide-mediated arterial hyporeactivity to phenylephrine in rats with ligated bile duct. , 1998, Scandinavian journal of gastroenterology.
[116] G. Stalder,et al. Hyposensitivity to nerve stimulation in portal hypertensive rats: role of nitric oxide , 1997, European journal of clinical investigation.
[117] Shuh Narumiya,et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension , 1997, Nature.
[118] J. Crespo,et al. Plasma adrenomedullin levels in patients with hepatic cirrhosis. , 1997, The American journal of gastroenterology.
[119] S. D. Lee,et al. Hyperdynamic circulation of cirrhotic rats with ascites: role of endotoxin, tumour necrosis factor-alpha and nitric oxide. , 1997, Clinical science.
[120] R. Stauber,et al. Nitric oxide‐dependent and ‐independent vascular hyporeactivity in mesenteric arteries of portal hypertensive rats , 1997, British journal of pharmacology.
[121] P. Sogni,et al. Induction of nitric oxide synthase II does not account for excess vascular nitric oxide production in experimental cirrhosis. , 1997, Journal of hepatology.
[122] R. Moreau,et al. Plasma concentrations of cyclic 3′,5′‐guanosine monophosphate in patients with cirrhosis: Relationship with atrial natriuretic peptide and haemodynamics , 1997, Journal of gastroenterology and hepatology.
[123] N. Bunnett,et al. Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. , 1997, The Biochemical journal.
[124] W. Jiménez,et al. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. , 1996, Hepatology.
[125] J. García-Estañ,et al. Vascular hyporesponsiveness in aortic rings from cirrhotic rats: role of nitric oxide and endothelium. , 1996, Clinical science.
[126] K. Morris,et al. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats , 1996, Hepatology.
[127] S. S. Lee,et al. Cirrhotic cardiomyopathy: Getting to the heart of the matter , 1996, Hepatology.
[128] R. Groszmann,et al. Thalidomide inhibits tumor necrosis factor α, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal‐hypertensive rats , 1996, Hepatology.
[129] S. Orlov,et al. cAMP signaling inhibits dihydropyridine-sensitive Ca2+ influx in vascular smooth muscle cells. , 1996, Hypertension.
[130] R. Schrier,et al. Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats. , 1996, The American journal of physiology.
[131] R. Sabra,et al. Adenosine does not mediate renal sodium retention and peripheral vasodilation elicited by partial portal vein ligation in rats , 1996, Hepatology.
[132] G. Burnstock,et al. Mesenteric vasodilator responses in cirrhotic rats: A role for nitric oxide , 1996, Hepatology.
[133] R. Schrier,et al. Endothelium‐dependent vascular hyporesponsiveness without detection of nitric oxide synthase induction in aortas of cirrhotic rats , 1995, Hepatology.
[134] R. Schrier,et al. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. , 1995, Gastroenterology.
[135] J. Wallace,et al. Impaired vasodilatory responses in the gastric microcirculation of anesthetized rats with secondary biliary cirrhosis. , 1995, Gastroenterology.
[136] R. Pilz,et al. Basis of guanylate cyclase activation by carbon monoxide. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[137] R. Groszmann,et al. Tumor necrosis factor α: A major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats , 1995 .
[138] H. Lin,et al. Change in vascular cAMP and cGMP contents in portal hypertensive rats. , 1995, Pharmacology.
[139] R. Moreau,et al. Lack of vascular hyporesponsiveness to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosis. , 1995, Journal of hepatology.
[140] R. Groszmann,et al. Tumor necrosis factor alpha: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. , 1995, Gastroenterology.
[141] P. Pizcueta,et al. Effects of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat. , 1994, The American journal of physiology.
[142] V. Arroyo,et al. Increased nitric oxide—dependent vasorelaxation in aortic rings of cirrhotic rats with ascites , 1994, Hepatology.
[143] N. Mcintyre,et al. Alteration in vascular reactivity in isolated aortic rings from portal vein—constricted rats , 1994, Hepatology.
[144] R. Moreau,et al. Vascular hyporesponsiveness to endothelin 1 in rats with cirrhosis. , 1994, Gastroenterology.
[145] P. Cahill,et al. Altered adenylyl cyclase activities and G-protein abnormalities in portal hypertensive rabbits. , 1994, The Journal of clinical investigation.
[146] M. Marletta,et al. Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. , 1994, Biochemistry.
[147] Han‐Chieh Lin,et al. Study on the vascular reactivity and α1‐adrenoceptors of portal hypertensive rats , 1994 .
[148] J. Kuo,et al. Study on the vascular reactivity and alpha 1-adrenoceptors of portal hypertensive rats. , 1994, British journal of pharmacology.
[149] R. Moreau,et al. Altered control of vascular tone by adenosine triphosphate-sensitive potassium channels in rats with cirrhosis. , 1994, Gastroenterology.
[150] J. Prieto,et al. Atrial natriuretic factor in cirrhosis: relationship to renal function and hemodynamic changes. , 1994, Journal of hepatology.
[151] N. Mcintyre,et al. Altered prostacyclin synthesis by aortae from hepatic portal vein-constricted rats: evidence for effects on protein kinase C and calcium. , 1994, Journal of hepatology.
[152] R. Moreau,et al. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension , 1993, Hepatology.
[153] R. Groszmann,et al. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats , 1992, Hepatology.
[154] R. Groszmann,et al. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. , 1992, Gastroenterology.
[155] R. Moreau,et al. Effects of theophylline on hemodynamics and tissue oxygenation in patients with cirrhosis. , 1992, Journal of hepatology.
[156] M. Navasa,et al. Lymphocyte beta 2-adrenoceptors and plasma catecholamines in patients with cirrhosis. , 1992, Gastroenterology.
[157] R. Groszmann,et al. In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade. , 1992, The American journal of physiology.
[158] E. Chilton,et al. Adenosine receptor blockade reduces splanchnic hyperemia in cirrhotic rats , 1992, Hepatology.
[159] R. Groszmann,et al. Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portal‐hypertensive rats , 1992, Hepatology.
[160] R. Moreau,et al. Blockade of ATP-sensitive K+ channels by glibenclamide reduces portal pressure and hyperkinetic circulation in portal hypertensive rats. , 1992, Journal of hepatology.
[161] C. Gaudin,et al. Adenosine and hemodynamic alterations in cirrhotic rats. , 1991, The American journal of physiology.
[162] A. Gerbes. Ascites and renal dysfunction in liver disease , 1989 .
[163] Vicente Arroyo,et al. Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis , 1988, Hepatology.
[164] R. Schrier,et al. Elevated Plasma Norepinephrine Concentrations in Decompensated Cirrhosis: Association with Increased Secretion Rates, Normal Clearance Rates, and Suppressibility by Central Blood Volume Expansion , 1985, Circulation research.
[165] N. Christensen,et al. Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis. , 1984, Gut.
[166] J. Stull,et al. Regulation of Myosin Phosphorylation in Smooth Muscle , 1984 .
[167] S. Kobayashi,et al. Relationship between cyclic AMP-dependent protein kinase activation and Ca uptake increase of sarcoplasmic reticulum fraction of hog biliary muscles relaxed by cholecystokinin-C-terminal peptides. , 1982, Biochemical pharmacology.